19-Nortestosterone17-decanoate , 98% , 360-70-3

Synonym(s):
Nandrolone decanoate;19-Nortestosterone 17-decanoate;Decadurabolin;4-Estren-17β-ol-3-one 17-decanoate;17β-Hydroxy-19-nor-4-androsten-3-one 17-decanoate

CAS NO.：360-70-3

Empirical Formula: C28H44O3

Molecular Weight: 428.65

MDL number: MFCD00135100

EINECS: 206-639-3

PRODUCT Properties

• Melting point: 33-37°C
• alpha: 32 º
• Boiling point: 483.46°C (rough estimate)
• Density: 1.0406 (rough estimate)
• refractive index: 1.4700 (estimate)
• storage temp.: 2-8°C
• solubility: 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: 0.8 mg/mL
• form: powder
• color: white to light yellow
• Water Solubility: 664ug/L(37 ºC)
• InChIKey: JKWKMORAXJQQSR-MOPIKTETSA-N
• SMILES: [C@@]12([H])CC[C@H](OC(=O)CCCCCCCCC)[C@@]1(C)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] |&1:0,4,17,21,23,33,r|

Description and Uses

Nandrolone decanoate, also known as nandrolone caprinate, is an alkylated anabolic steroid indicated in the management of anemia of renal insufficiency and as an adjunct therapy in the treatment of senile and postmenopausal osteoporosis. The process for creating esters of [nandrolone] was patented in Spain in 1959 and in 1960, it was described as having a long duration of action and strong anabolic effect compared to nandrolone and other esters. Nandrolone decanoate was granted FDA approval on 5 October 1962.

Nandrolone Decanoate is an anabolic steroid. Nandrolone decanoate is used in the treatment of osteoporosis in postmenopausal women. Nandrolone Decanoate is also used for some aplastic anemias. Control led Substance.

Safety

• Symbol(GHS): GHS08
• Signal word: Danger
• Hazard statements: H351-H360FD
• Precautionary statements: P201-P202-P280-P308+P313-P405-P501
• Hazard Codes: Xn
• Risk Statements: 40
• Safety Statements: 22-36
• WGK Germany: 3
• RTECS: KG7967000
• HS Code: 2937290000
• Toxicity: LD50 intraperitoneal in mouse: > 566mg/kg